Evidence of abnormality of lymphocyte uroporphyrinogen synthase in family members of patients with lymphoproliferative diseases

Cancer Lett. 1985 Jan;25(3):305-10. doi: 10.1016/s0304-3835(15)30010-0.

Abstract

Patients with active lymphoproliferative diseases (LPD) were shown to have high activity of lymphocyte uroporphyrinogen synthase (L-UROS), the enzyme which converts porphobilinogen to uroporphyrinogen. The mean L-UROS activity of 64 first-degree relatives of patients with LPD was significantly higher than that of a control group and 45% of these relatives had pathological values of L-UROS. L-UROS activity was also determined in the spouses of 2 patients and was pathologically elevated in both. The pattern of pathological values among family members may indicate the presence of a communicable agent.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Ammonia-Lyases / blood*
  • Female
  • Hodgkin Disease / enzymology
  • Hodgkin Disease / genetics
  • Humans
  • Hydro-Lyases / blood*
  • Hydroxymethylbilane Synthase / blood*
  • Leukemia, Lymphoid / enzymology
  • Leukemia, Lymphoid / genetics
  • Lymphocytes / enzymology*
  • Lymphoma / enzymology
  • Lymphoma / genetics
  • Lymphoproliferative Disorders / enzymology*
  • Lymphoproliferative Disorders / genetics
  • Male
  • Middle Aged
  • Pedigree
  • Uroporphyrinogen III Synthetase / blood*

Substances

  • Hydroxymethylbilane Synthase
  • Hydro-Lyases
  • Uroporphyrinogen III Synthetase
  • Ammonia-Lyases